Back to results
US 2016/0355861 A1Published application
Method for producing gamma-glutamylvalylglycine or a salt thereof
AssigneeAjinomoto Co., Inc.
InventorsHiroyuki NOZAKI, Isao Abe, Jun Takakura, Rie Takeshita, Hideyuki Suzuki, Shunichi Suzuki
Life of this patent
Estimating the term…
Abstract
A method for producing γ-Glu-Val-Gly comprising the step of reacting Val-Gly with a γ-glutamyl group donor in the presence of a γ-glutamyltransferase, a microorganism containing the enzyme, or a processed product thereof to generate γ-Glu-Val-Gly, wherein the γ-glutamyltransferase consists of a large subunit and a small subunit, and the small subunit has a specific mutation.
Claims15
(canceled)
2:
- A method for producing γ-Glu-Val-Gly, comprising reacting Val-Gly with a γ-glutamyl group donor in the presence of a γ-glutamyltransferase, such that γ-Glu-Val-Gly is generated,
- wherein the γ-glutamyltransferase comprises a large subunit and a small subunit,
- the small subunit has an amino acid sequence having no less than 90% sequence identity to the amino acid sequence of the positions 391 to 580 of the amino acid sequence of SEQ ID NO:
- 2, wherein the tyrosine at the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion.
2 more elements
3:
- The method according to claim 2, wherein the tyrosine at the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine.
4:
- The method according to claim 2, wherein the small subunit has an amino acid substitution selected from the group consisting of Y444D, Y444E, Y444A, (T413A+Y444E), (T413H+Y444E), (T413N+Y444E), (Q430N+Y444E), (Q430N+Y444D), (Q430N+Y444N), (P441A+Y444E), (V443A+Y444E), (V443E+Y444E), (V443G+Y444E), (V443L+Y444E), (V443N+Y444E), (V443Q+Y444E), (Y444E+L446A), (Y444E+A453S), (Y444E+D472I), (Y444E+G484A), (Y444E+G484S), (Y444E+S498C), (Y444E+Q542H), (Y444E+D561N), (T413N+Y444E+V443A), (T413N+Y444E+A453S), (T413N+Y444E+S498C), (T413N+Y444E+Q542H), (G484S+Y444E+V443A), (G484S+Y444E+Q542H), (Q430N+Y444E+T413N), (T413H+Y444E+G484S), (T413N+Y444E+G484S), (T413N+Y444E+G484S+V443A), (T413N+Y444E+G484S+A453 S), (T413N+Y444E+G484S+Q542H), (T413N+Y444E+G484S+S572K) (T413N+Y444E+G484S+Q430N), and (T413N+Y444E+G484E+S498C), in SEQ ID NO:
- 2.
5:
- The method according to claim 2, wherein the small subunit has the amino acid sequence of SEQ ID NO:
- 13 except that the tyrosine at the position 44 of SEQ ID NO:
- 13 corresponding to the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion.
1 more element
6:
- The method according to claim 2, wherein the small subunit has the amino acid sequence of
- the positions 391 to 580 of SEQ ID NO:
- 2 except that the tyrosine at the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
- the positions 391 to 580 of SEQ ID NO:
- 3 except that the tyrosine at the position 444 of SEQ ID NO:
- 3 corresponding to the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
- the positions 392 to 581 of SEQ ID NO:
- 4 except that the tyrosine at the position 445 of SEQ ID NO:
- 4 corresponding to the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
- the positions 388 to 577 of SEQ ID NO:
- 5 except that the tyrosine at the position 441 of SEQ ID NO:
- 5 corresponding to the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
- the positions 391 to 580 of SEQ ID NO:
- 6 except that the tyrosine at the position 444 of SEQ ID NO:
- 6 corresponding to the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
- the positions 391 to 580 of SEQ ID NO:
- 7 except that the tyrosine at the position 444 of SEQ ID NO:
- 7 corresponding to the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
- the positions 391 to 580 of SEQ ID NO:
- 8 except that the tyrosine at the position 444 of SEQ ID NO:
- 8 corresponding to the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
- the positions 400 to 589 of SEQ ID NO:
- 9 except that the tyrosine at the position 453 of SEQ ID NO:
- 9 corresponding to the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
- the positions 391 to 580 of SEQ ID NO:
- 10 except that the tyrosine at the position 444 of SEQ ID NO:
- 10 corresponding to the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine,
- the positions 392 to 581 of SEQ ID NO:
- 11 except that the tyrosine at the position 445 of SEQ ID NO:
- 11 corresponding to the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine, or
- the positions 392 to 581 of SEQ ID NO:
- 12 except that the tyrosine at the position 445 of SEQ ID NO:
- 12 corresponding to the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine.
41 more elements
7:
- The method according to claim 2, wherein the γ-glutamyl group donor is L-glutamine or a salt thereof.
8:
- The method according to claim 2, wherein the reacting of Val-Gly with the γ-glutamyl group donor occurs in the presence of a microorganism containing the γ-glutamyltransferase, and the microorganism containing the γ-glutamyltransferase is a bacterium belonging to Enterobacteriaceae.
9:
- The method according to claim 8, wherein the microorganism containing the γ-glutamyltransferase is an Escherichia bacterium.
10:
- The method according to claim 9, wherein the microorganism containing the γ-glutamyltransferase is Escherichia coli.
11:
- The method according to claim 8, wherein the microorganism containing the γ-glutamyltransferase is deficient in peptidase D.
12:
- The method according to claim 2, wherein the reacting of Val-Gly with the γ-glutamyl group donor occurs in the presence of a metal chelating agent.
13:
- The method according to claim 2,
- wherein the reacting of Val-Gly with the γ-glutamyl group donor occurs in the presence of a microorganism containing the γ-glutamyltransferase or a processed product of the microorganism, and
- the processed product of the microorganism has enzymatic activity of the γ-glutamyltransferase and is selected from the group consisting of a disrupted cell of the microorganism, an extract of the microorganism, a partially purified product of the microorganism, a purified product of the γ-glutamyltransferase, an acrylamide- or carrageenan immobilized cell of the microorganism, and the γ-glutamyltransferase immobilized on a solid phase.
14:
- The method according to claim 2, wherein the small subunit has the amino acid sequence of SEQ ID NO:
- 13 except that the tyrosine at the position 44 of SEQ ID NO:
- 13 corresponding to the position 444 of SEQ ID NO:
- 2 is substituted with aspartic acid, glutamic acid, asparagine, or alanine.
1 more element
15:
- The method according to claim 2, wherein the small subunit has the amino acid sequence of
- the positions 391 to 580 of SEQ ID NO:
- 3 except that the tyrosine at the position 444 of SEQ ID NO:
- 3 corresponding to the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion,
- the positions 392 to 581 of SEQ ID NO:
- 4 except that the tyrosine at the position 445 of SEQ ID NO:
- 4 corresponding to the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion,
- the positions 388 to 577 of SEQ ID NO:
- 5 except that the tyrosine at the position 441 of SEQ ID NO:
- 5 corresponding to the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion,
- the positions 391 to 580 of SEQ ID NO:
- 6 except that the tyrosine at the position 444 of SEQ ID NO:
- 6 corresponding to the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion,
- the positions 391 to 580 of SEQ ID NO:
- 7 except that the tyrosine at the position 444 of SEQ ID NO:
- 7 corresponding to the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion,
- the positions 391 to 580 of SEQ ID NO:
- 8 except that the tyrosine at the position 444 of SEQ ID NO:
- 8 corresponding to the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion,
- the positions 400 to 589 of SEQ ID NO:
- 9 except that the tyrosine at the position 453 of SEQ ID NO:
- 9 corresponding to the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion,
- the positions 391 to 580 of SEQ ID NO:
- 10 except that the tyrosine at the position 444 of SEQ ID NO:
- 10 corresponding to the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion,
- the positions 392 to 581 of SEQ ID NO:
- 11 except that the tyrosine at the position 445 of SEQ ID NO:
- 11 corresponding to the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion, or
- the positions 392 to 581 of SEQ ID NO:
- 12 except that the tyrosine at the position 445 of SEQ ID NO:
- 12 corresponding to the position 444 of SEQ ID NO:
- 2 is modified by substitution, deletion, insertion, addition, or inversion.
38 more elements
Dependencies are inferred from the claim text.